Impact of 25% Albumin on Vasopressor Requirements in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
In CTICU patients receiving CRRT and vasopressors, 25% albumin resulted in no statistically significant difference in average vasopressor requirements in the 48 hours prealbumin compared to the 48 hours postalbumin in the unadjusted model. However, multivariable regression demonstrated a significant association between albumin administration and reduced vasopressors during the 48-hour period following albumin.
Authors
- Daniel L Gilstrap
- Cory Vatsaas (ORCID: https://orcid.org/0000-0002-1135-6470)
- Ashley Howard (ORCID: https://orcid.org/0000-0001-5505-0214)
- Kelsey Ohman (ORCID: https://orcid.org/0000-0003-4248-5838)
- Alaattin Erkanli
- Michelle Sharpe
- Zidanyue Yang (ORCID: https://orcid.org/0000-0002-4843-4313)
- Julia K. Lessing (ORCID: https://orcid.org/0009-0005-3723-8930)
- Jerrold H Levy
Institutions
- Duke University (US)
- Mount Sinai Medical Center (US)
- Duke Medical Center (US)
- Duke University Hospital (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1177/10600280251384651
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00